Сигналы
1
u/Qwerty_gu
Reddit r/ValueInvesting
Винрейт
100.0%
доходность
+23.1%
Загрузка графиков...
Тикер
Сторона
Упоминания
Первый колл
Цена колла
P&L
Тезис
Тема
Источник
Лонг
15 мар
$37.96
+23.1%
The market for obesity treatments and GLP-1 therapies is large and growing, with structural long-term demand. The current market price of Novo Nordisk (EUR 33.1) does not fully reflect this long-term growth potential, leading to an undervaluation compared to the author's calculated fair value (EUR 47.7). Novo Nordisk is undervalued because the market underestimates the size and durability of the obesity drug market, presenting a long-term buying opportunity. Increased competition, pricing pressure from payers, unexpected side effects from GLP-1 drugs, or a slowdown in market adoption could invalidate the thesis.
The market for obesity treatments and GLP-1 therapies is large and growing, with structural long-term demand. The current market price of Novo Nordisk (EUR 33.1) does not fully reflect this long-term growth potential, leading to an undervaluation compared to the author's calculated fair value (EUR 47.7). Novo Nordisk is undervalued because the market underestimates the size and durability of the obesity drug market, presenting a long-term buying opportunity. Increased competition, pricing pressure from payers, unexpected side effects from GLP-1 drugs, or a slowdown in market adoption could invalidate the thesis.
GLP-1 / Ожирение
Показано 1 из 1 коллов · сортировка по упоминаниям
Выберите число упоминаний, чтобы открыть посты по тикеру.
У u/Qwerty_gu на Buzzberg отслеживается 1 торговых идей по 1 тикерам с марта 2026. Чаще всего покрывает: NVO.
